Clinico-immunological evaluation of use of omega-3 fatty acids as nutraceutical approach in management of patients with chronic periodontitis: A randomized clinical trial
- PMID: 39071748
- PMCID: PMC11280262
- DOI: 10.1016/j.mjafi.2024.04.013
Clinico-immunological evaluation of use of omega-3 fatty acids as nutraceutical approach in management of patients with chronic periodontitis: A randomized clinical trial
Abstract
Background: Subgingival bacterial colonization and biofilm formation are known to be the main etiology of periodontal disease progression. This biofilm elicits host response and the interaction between host defence mechanisms with plaque microorganisms and their products results in periodontal disease. Host modulatory therapy (HMT) is a form of treatment of periodontitis that focuses on treatment of the host in the host-bacteria interaction. Omega-3 fatty acids have emerged as a potential HMT agent to treat inflammation associated with periodontal disease.
Methods: A total of 60 cases of chronic periodontitis were allocated into two groups; the test group (n = 30) were treated with scaling and root planing (SRP) and given a dietary supplementation of omega-3 fatty acid while the control group were treated with SRP alone. Clinical parameters carried out were plaque index (PI), gingival bleeding index (GBI), pocket probing depth (PPD) and clinical attachment level (CAL) and immunological parameter included interleukin-1β level in saliva at baseline, 3 months and 6 months after therapy.
Results: At 6 months, both the groups showed significant improvements with regards to all clinical and immunological parameters compared to baseline (all p < 0.05). However, test group presented with more favourable statistically significant results.
Conclusion: The use of omega-3 fatty acid as nutraceutical agent to conventional method acted as beneficial therapeutic measures and effective in patients with chronic periodontitis when compared with SRP alone.
Keywords: Host modulation; Interleukin-1 β; Omega-3 fatty acid; Periodontitis.
© 2024 Director General, Armed Forces Medical Services. Published by Elsevier, a division of RELX India Pvt. Ltd.
Conflict of interest statement
The authors have none to declare.
Figures









Similar articles
-
Full-mouth treatment modalities (within 24 hours) for periodontitis in adults.Cochrane Database Syst Rev. 2022 Jun 28;6(6):CD004622. doi: 10.1002/14651858.CD004622.pub4. Cochrane Database Syst Rev. 2022. PMID: 35763286 Free PMC article.
-
The effect of omega-3 fatty acids on active periodontal therapy: A systematic review and meta-analysis.J Clin Periodontol. 2022 Oct;49(10):1024-1037. doi: 10.1111/jcpe.13680. Epub 2022 Jul 21. J Clin Periodontol. 2022. PMID: 35713248 Free PMC article.
-
Local anti-infective therapy: pharmacological agents. A systematic review.Ann Periodontol. 2003 Dec;8(1):79-98. doi: 10.1902/annals.2003.8.1.79. Ann Periodontol. 2003. PMID: 14971250
-
Periodontal host modulation with antiproteinase, anti-inflammatory, and bone-sparing agents. A systematic review.Ann Periodontol. 2003 Dec;8(1):12-37. doi: 10.1902/annals.2003.8.1.12. Ann Periodontol. 2003. PMID: 14971246
-
Treatment of periodontitis for glycaemic control in people with diabetes mellitus.Cochrane Database Syst Rev. 2022 Apr 14;4(4):CD004714. doi: 10.1002/14651858.CD004714.pub4. Cochrane Database Syst Rev. 2022. PMID: 35420698 Free PMC article.
References
-
- Offenbacher S. Periodontal diseases: pathogenesis. Ann Periodontol. 1996 Nov;1(1):821–878. - PubMed
-
- Cobb C.M. Non-surgical pocket therapy: mechanical. Ann Periodontol. 1996 Nov;1(1):443–490. - PubMed
-
- Kaye E.K. n-3 fatty acid intake and periodontal disease. J Am Diet Assoc. 2010;27 Published October. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous